Atlas Trials

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

Clinical trial NCT01899053 · COMPLETED

Trial details

NCT number
NCT01899053
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Nonhematologic Malignancies
Start date
2013-06-28
Primary completion
2017-01-31
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.